Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing ropanicant for Depression.
Multiple locations, including Little RockThis study is completed in the United States. It is testing NRCT-101SR for ADHD.
Multiple locations, including Garden GroveThis study was terminated in the United States. It is testing NRCT-101SR for ADHD.
Multiple locations, including Anaheim
This study is completed in the United States. It is testing potential Predictors of Relapse for depression.
Multiple locations, including Birmingham
This study is completed in the United States. It is testing Safety & Efficacy of d-Amphetamine Transdermal System for ADHD.
Multiple locations, including IrvineThis study was terminated in the United States. It is testing safety & Efficacy of NaBen® for schizophrenia.
In PasadenaThis study is completed in the United States. It focuses on ADHD.
In Salt Lake CityThis study is completed in Japan. It is testing Effect and Safety of Quetiapine Extended Release (XR) for depression.
Multiple locations, including HokkaidouThis study was terminated in the United States, in Switzerland, in Bulgaria, .... It is testing Effect of AFQ056 for OCD.
Multiple locations, including San DiegoThis study is completed in the United States. It is testing Effects of Oral NMRA-335140 for depression.
Multiple locations, including HuntsvilleThis study is completed in Japan. It is testing Effects of Switching Different Strength Forms of FK949E for depression.
Multiple locations, including FukushimaThis study is completed in Brazil. It is testing Efficacy and Quality of Life of Long-Acting Methylphenidate for ADHD.
Multiple locations, including Belo HorizonteHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.